SAGILITY
Sagility share price & financials
- Price
- ₹41.75
- Market cap
- ₹20.2k Cr
- Sector
- Information Technology
- Calls analysed
- 8
Sagility Limited Q1 FY27
What went well
- Revenue for Q1 FY27 was INR 19,635 million ($207.8 million), representing 27.6% year-on-year growth and 15.2% growth in constant currency.
- Adjusted EBITDA grew 27.9% year-on-year to INR 4,716 million ($49.9 million), with a margin of 24%.
- Adjusted PAT increased to INR 2,697 million ($28.6 million), up 35.1% year-on-year with a margin of 13.7%.
What to watch
- The statutory minimum wage revisions in Karnataka and Telangana are estimated to have an incremental impact of approximately 120 basis points on FY27 adjusted EBITDA.
- The business follows a predictable seasonal pattern driven by the U.S. open enrolment cycle, leading to sequential revenue decline versus Q4 FY26.
What Sagility Limited does
Sagility is a pure-play, 100% US-healthcare-focused business process management company that runs outsourced back-office and clinical-support operations for health insurers (payers), pharmacy benefit managers (PBMs) and healthcare providers. It earns fees by handling payer-side workflows such as member and provider lifecycle management, claims processing, prior authorization, utilization/case management and payment-integrity audits, as well as provider-side revenue-cycle management (benefit verification, coding, denials management and underpayment recovery). Delivery combines human operations staff (including nurses and clinicians) with proprietary AI/automation tools (e.g., SmarTec agents) across a multi-shore network spanning India, the Philippines, Jamaica, Colombia and the US. It also offers outcome-based managed-services and technology-platform ("Synchrony") engagements that bundle operations with client-side technology.
Segments
- Payer & PBM Practice
- Provider Practice
- Healthcare associates (workforce)
- 40,000+
- Delivery centers
- 35
- Geographies of operation
- 5 (India, Philippines, Jamaica, Colombia, U.S.)
- Clinicians and technology experts
- 4,100+
- Healthcare clients served
- 80+
- Top-10 U.S. payers served
- 7 of the top 10
Guidance record · Q1 FY27
what the last two calls moved 14 tracked 2 delivered 4 missed 8 open- FY25 Revenue Growth (CC) delivered said Q2 FY25 Promised: In line with H1 performance (~13.8% CC) Q1 FY27: Target remains achieved from FY25.
- FY26 Total Revenue Growth (CC) went quiet said Q4 FY25 Promised: >20% Q1 FY27: The final full-year FY26 growth figure was not explicitly reported in the Q1 FY27 results, leaving the final status against the 22.5% CC guidance unconfirmed.
- New Client Additions on track said Q2 FY25 Promised: 8-12 per year Q1 FY27: Added 1 new logo in Q1 FY27, which is on track for the annual target of 8-12 for FY27. Additionally, acquired 26 new clients via the CareSeed acquisition.
All 14 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q1 FY27: revenue up 27.6%, net profit up 45.6% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,325 | 1,453 | 1,568 | 1,539 | 1,658 +25% | 1,971 +36% | 2,024 +29% | 1,963 +28% |
| EBITDA | 301 | 392 | 373 | 346 | 415 +38% | 511 +30% | 485 +30% | 438 +27% |
| Net profit | 117 | 217 | 183 | 149 | 251 +115% | 268 +24% | 258 +41% | 217 +46% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +2.1% 1Y
1Y: ₹44.27 on 10 Sept 2025 → ₹45.2. High ₹54.58 (30 Oct 2025), low ₹36.35 (23 Mar 2026).
How the price took the results
close before → close after
- Q1 FY27
- +1.3%
- 21 Jul
- Q4 FY26
- +6.9%
- 25 Mar
- Q3 FY26
- −0.9%
- 28 Jan
- Q2 FY26
- +2.6%
- 29 Oct
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Financials, as filed
Revenue grew 23.0% a year over 2 years, FY24 to FY26. Operating margin widened to 24.4%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹4.8k Cr | ₹5.6k Cr | ₹7.2k Cr |
| Operating profit | ₹1.1k Cr | ₹1.3k Cr | ₹1.8k Cr |
| Operating margin | 22.4% | 22.6% | 24.4% |
| Interest | ₹185 Cr | ₹127 Cr | ₹99 Cr |
| Depreciation | ₹689 Cr | ₹466 Cr | ₹488 Cr |
| Net profit | ₹228 Cr | ₹539 Cr | ₹926 Cr |
| Net margin | 4.8% | 9.7% | 12.9% |
| ROCE | 5.0% | 10.0% | 13.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Equity capital | ₹1.9k Cr | ₹1.9k Cr | ₹4.3k Cr | ₹4.7k Cr | ₹4.7k Cr |
| Reserves | ₹2.1k Cr | ₹4.3k Cr | ₹2.2k Cr | ₹4.2k Cr | ₹5.0k Cr |
| Borrowings | ₹4.8k Cr | ₹2.9k Cr | ₹2.5k Cr | ₹1.2k Cr | ₹1.1k Cr |
| Other liabilities | ₹1.3k Cr | ₹1.4k Cr | ₹1.6k Cr | ₹1.4k Cr | ₹1.7k Cr |
| Total liabilities | ₹10.1k Cr | ₹10.5k Cr | ₹10.5k Cr | ₹11.5k Cr | ₹12.4k Cr |
| Fixed assets | ₹8.6k Cr | ₹8.6k Cr | ₹8.7k Cr | ₹9.1k Cr | ₹9.4k Cr |
| Capital work in progress | ₹5 Cr | ₹0 Cr | ₹6 Cr | ₹0 Cr | ₹43 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹247 Cr | ₹336 Cr |
| Other assets | ₹1.5k Cr | ₹1.9k Cr | ₹1.9k Cr | ₹2.2k Cr | ₹2.7k Cr |
| Total assets | ₹10.1k Cr | ₹10.5k Cr | ₹10.5k Cr | ₹11.5k Cr | ₹12.4k Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, promoters trimmed −16.43 pp while DIIs added +7.35 pp. The shareholder count grew 34% to 5,38,679.
- Promoters
- 51.0%
- FIIs
- 10.0%
- DIIs
- 21.4%
- Public
- 17.6%
Since Jun 2025
- Promoters −16.43 pp
- DIIs +7.35 pp
- Public +5.08 pp
How it drifted, 7 quarters
Over this window promoters fell from 82.4% to 51.0% — −31.4 pp.
Ownership split by quarter, oldest first. Dec '24: Promoters 82.4%, FIIs 3.8%, DIIs 7.3%, Public 6.6%.Mar '25: Promoters 82.4%, FIIs 3.4%, DIIs 7.5%, Public 6.8%.Jun '25: Promoters 67.4%, FIIs 6.0%, DIIs 14.1%, Public 12.6%.Sep '25: Promoters 67.4%, FIIs 5.6%, DIIs 14.9%, Public 12.2%.Dec '25: Promoters 51.0%, FIIs 10.3%, DIIs 21.4%, Public 17.4%.Mar '26: Promoters 51.0%, FIIs 10.0%, DIIs 22.3%, Public 16.8%.Jun '26: Promoters 51.0%, FIIs 10.0%, DIIs 21.4%, Public 17.6%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- ICICI Prudential Technology Fund Mutual fund +0.33 pp 3.48% held
- Government Pension Fund Global Sovereign +0.11 pp 1.69% held
The same filing shows 1 holder trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Sagility Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Sagility B.V | 50.95% | unchanged |
| ICICI Prudential Technology Fund Mutual fund | 3.48% | +0.33 pp |
| Axis Max Life Insurance Limited A/C Reversionary Bonus Participating - Equity Insurer | 2.83% | unchanged |
| Government Pension Fund Global Sovereign | 1.69% | +0.11 pp |
| Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund A/C Axis Small Cap Fund Mutual fund | 1.41% | unchanged |
| Canara Robeco Mutual Fund A/C Canara Robeco Small Cap Fund Mutual fund | 1.36% | unchanged |
| Baroda BNP Paribas Multi Cap Fund Mutual fund | 1.21% | −0.27 pp |
| Kotak Small Cap Fund Mutual fund | 1.20% | unchanged |
| Sagility Holdings B.V. | 0.00% | unchanged |
| Sagility Mezz B.V. | 0.00% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Mutual funds in SAGILITY
Filings to Aug 2026
2 new, 4 added, 1 trimmed, 0 sold out — net +16.38 L shares (+4.1%).
- Held by funds
- ₹182 Cr
- 11 schemes
- Biggest holder
- HDFC Children's Fund
- ₹65 Cr · 0.6% of that fund
| Scheme | Holding | Last month | Held since |
|---|---|---|---|
| HDFC Children's Fund HDFC Mutual Fund | ₹65 Cr | held | Nov '24 |
| HDFC Technology Fund HDFC Mutual Fund | ₹35 Cr | held | Nov '24 |
| HDFC Dividend Yield Fund HDFC Mutual Fund | ₹28 Cr | held | May '25 |
| HDFC Business Cycle Fund HDFC Mutual Fund | ₹19 Cr | held | Nov '24 |
| Nippon India Nifty Smallcap 250 Index Fund Nippon India Mutual Fund | ₹17 Cr | +0.45 L | Mar '25 |
| SBI Nifty Smallcap 250 Index Fund SBI Mutual Fund | ₹9 Cr | +0.21 L | Mar '25 |
| Nippon India Arbitrage Fund Nippon India Mutual Fund | ₹4 Cr | new | Aug '26 |
| SBI Arbitrage Fund SBI Mutual Fund | ₹3 Cr | new | Aug '26 |
HDFC, Nippon India and SBI schemes, from their monthly disclosures. Changes are counted in shares, so a price move never looks like buying or selling.
Mutual funds Aug 2026
4 added, 1 trimmed — net +16.38 L shares (+4.1%)
- Funds are sitting on
- +4%
- vs est. average cost
- Held by funds
- ₹182 Cr
- 11 schemes · ≈ 0.86% of the company
- Biggest holder
- HDFC Children's Fund
- ₹65 Cr · 0.6% of that fund
Shares held by these funds +12%
Nov '24 3.98 cr shares Jul '26
What the price assumes
AttractiveTo justify its price of ₹45, this stock must grow earnings at 14% every year for 7 years. Our analysis caps realistic growth at ~96%. At that growth it is worth ₹1565 — upside of 3362%.
- Growth the price implies
- 14.2% a year
- for 7 years, fading to 4%
- It has actually compounded at
- 96.3% a year
- net profit, FY24–FY26
- The gap
- -0.8 pp
- 3362% downside if it only repeats history
All earnings calls (7)
Read the Q1 FY27 call →Learn to analyse Sagility Limited
Guides on how to read this kind of business and the numbers that matter.